Article Cited by others


Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial

Chawla Shalini, Kaushik Nitin, Singh Narinder Pal, Ghosh Raktim Kumar, Saxena Alpana

Year : 2013| Volume: 4| Issue : 1 | Page no: 27-32

   This article has been cited by
1 Enhancement of cognitive functions by rice bran extract in a neuroinflammatory mouse model via regulation of PPAR?
A.O. Mostafa,R.M. Abdel-Kader,O.A. Heikal
Journal of Functional Foods. 2018; 48: 314
[Pubmed]  [Google Scholar] [DOI]
2 Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
Elena Filipova,Katya Uzunova,Krassimir Kalinov,Toni Vekov
Diabetology & Metabolic Syndrome. 2017; 9(1)
[Pubmed]  [Google Scholar] [DOI]
3 Network meta-analysis of lorcaserin and oral hypoglycaemics for patients with type 2 diabetes mellitus and obesity
L. M. Neff,M. S. Broder,D. Beenhouwer,E. Chang,E. Papoyan,Z. W. Wang
Clinical Obesity. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report
SarayuA Pai,NilimaA Kshirsagar
Indian Journal of Medical Research. 2016; 144(5): 672
[Pubmed]  [Google Scholar] [DOI]
5 Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Surjit Singh,Anil Bhansali
BMC Dermatology. 2016; 16(1)
[Pubmed]  [Google Scholar] [DOI]
6 The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients
Nasser Aghamohammadzadeh,Mitra Niafar,Elham Dalir Abdolahinia,Farzad Najafipour,Saeed Mohamadzadeh Gharebaghi,Khadijeh Adabi,Elaheh Dalir Abdolahinia,Hamidreza Ahadi
Therapeutic Advances in Endocrinology and Metabolism. 2015; 6(2): 56
[Pubmed]  [Google Scholar] [DOI]
7 Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
Elizabeth S. Mearns,Diana M. Sobieraj,C. Michael White,Whitney J. Saulsberry,Christine G. Kohn,Yunes Doleh,Eric Zaccaro,Craig I. Coleman,Wen-Chih Hank Wu
PLOS ONE. 2015; 10(4): e0125879
[Pubmed]  [Google Scholar] [DOI]
8 Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
Elena Pavlova Filipova,Katya Hristova Uzunova,Toni Yonkov Vekov
Diabetology & Metabolic Syndrome. 2015; 7(1)
[Pubmed]  [Google Scholar] [DOI]
9 Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study
M. Bajaj,R. Gilman,S. Patel,J. Kempthorne-Rawson,D. Lewis-DęAgostino,H.-J. Woerle
Diabetic Medicine. 2014; 31(12): 1505
[Pubmed]  [Google Scholar] [DOI]


Read this article